Doctolib has surpassed €400 million in annual revenue and is welcoming new investors into its capital structure, marking a significant milestone for the French healthtech leader.

The company, which operates a platform for booking medical appointments and provides software tools for healthcare professionals, reported revenues exceeding €400 million for its last fiscal year. This growth is attributed to the continued expansion of its subscriber base among doctors and medical facilities, as well as the development of its enterprise solutions for hospitals and clinics.

As part of this new phase, Doctolib is bringing on board additional investors. While the specific names and the exact amount of new funding were not disclosed in the initial report, this move signals a strategic step to fuel further growth, potentially for international expansion, technological development, or new service offerings. The company, already backed by major funds like Eurazeo, General Atlantic, and Bpifrance, has become a central pillar in the digitalization of the French healthcare sector.

This financial performance solidifies Doctolib's dominant position in the European e-health market. The influx of new investors provides fresh capital to accelerate its ambitions, likely focusing on consolidating its presence in existing markets like France, Germany, and Italy, and possibly exploring new territories or adjacent healthcare services.

L’article Doctolib dépasse les 400 millions de revenus et fait entrer de nouveaux investisseurs est apparu en premier sur Maddyness - Le média pour comprendre l'économie de demain.